Re: Employment AgreementEmployment Agreement • March 18th, 2013 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
On behalf of BG Medicine, Inc. (the “Company”), and the entire Board of Directors of the Company (the “Board”), I am delighted to offer you employment with the Company. This offer letter agreement (the “Agreement”) describes the terms and conditions of such employment.
CONSULTING AGREEMENTConsulting Agreement • March 18th, 2013 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
This Consulting Agreement (this “Agreement”) between Neal Gordon having an address at 6 Scott Road, Lexington, MA 02421 (the “Consultant”) and BG Medicine, Inc., (the “Company”), a Delaware corporation having a principal place of business at 610N Lincoln Street, Waltham, MA 02451, is made effective as of January 1, 2013 (the “Effective Date”). In consideration of the mutual promises and covenants set forth herein, the sufficiency of which is hereby acknowledged, the parties hereby agree as follows:
Re: Side Letter Agreement Regarding Terms and Conditions of EmploymentBG Medicine, Inc. • March 18th, 2013 • In vitro & in vivo diagnostic substances
Thank you for the recent discussions regarding modifications to the terms and conditions of your employment, as currently in effect. We are providing you with this letter agreement (the “Side Letter Agreement”), to outline the terms and conditions of these modifications, as agreed between you and BG Medicine, Inc. (the “Company”). These terms and conditions became effective on October 4, 2012 (the “Effective Date”).
Re: Severance Agreement and ReleaseLetter Agreement • March 18th, 2013 • BG Medicine, Inc. • In vitro & in vivo diagnostic substances • Massachusetts
This letter agreement (hereinafter the “Agreement”) confirms the terms of your separation from BG Medicine, Inc. (“BG Medicine” or “Company”). The consideration described below is contingent on your agreement to and compliance with the terms of this Agreement. The Effective Date of this Agreement shall be the eighth (8th) day following the day that you sign it, as described more fully in Section 10 below.
December 7, 2012 Anastasia (Stacie) Rader Sudbury, MA 01776BG Medicine, Inc. • March 18th, 2013 • In vitro & in vivo diagnostic substances
Thank you for your discussions and cooperation regarding your proposed new employment terms. We are providing you with this letter agreement (the “Side Letter Agreement”) to outline the modifications to your compensation and other employment terms, as agreed between you and BG Medicine, Inc. (the “Company”).
